Pleiotropy of microRNA-192 in the kidney

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 762-767

  Jenkins, Robert H ^a   Martin, John ^b   Phillips, Aled O ^b   Bowen, Timothy ^b   Fraser, Donald J ^b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Hepatocyte nuclear factor (HNF); MicroRNA (miRNA); p53; Renal fibrosis; Transcription

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HOMEODOMAIN PROTEIN; MICRORNA; MICRORNA 192; MICRORNA 34A; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZINC FINGER E BOX BINDING HOMEOBOX PROTEIN 1; ZINC FINGER E BOX BINDING HOMEOBOX PROTEIN 2;

B CELL LYMPHOMA; CELL CYCLE; CELL DIFFERENTIATION; CONFERENCE PAPER; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; HUMAN; KIDNEY; KIDNEY CORTEX; KIDNEY FIBROSIS; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; RNA PROCESSING;

ANIMALS; FIBROSIS; HEPATOCYTE NUCLEAR FACTORS; HUMANS; KIDNEY; KIDNEY DISEASES; MICRORNAS;

EID: 84864379328     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120085     Document Type: Conference Paper

References (48)

1. Bhatt, K., Mi, Q.S. and Dong, Z. (2011) microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am. J. Physiol. Renal Physiol. 300, F602-F610
2. Sun, Y., Koo, S., White, N., Peralta, E., Esau, C., Dean, N.M. and Perera, R.J. (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 32, e188
3. Tian, Z., Greene, A.S., Pietrusz, J.L., Matus, I.R. and Liang, M. (2008) MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res. 18, 404-411 (Pubitemid 351347083)
4. Krupa, A., Jenkins, R., Luo, D.D., Lewis, A., Phillips, A. and Fraser, D. (2010) Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 21, 438-447
5. Wang, B., Herman-Edelstein, M., Koh, P., Burns, W., Jandeleit-Dahm, K., Watson, A., Saleem, M., Goodall, G.J., Twigg, S.M., Cooper, M.E. and Kantharidis, P. (2010) E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-β. Diabetes 59, 1794-1802
6. Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J.J. and Natarajan, R. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U.S.A. 104, 3432-3437 (Pubitemid 46364176)
7. Kato, M., Arce, L., Wang, M., Putta, S., Lanting, L. and Natarajan, R. (2011) A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney Int. 80, 358-368
8. Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., Rossi, J.J. and Natarajan, R. (2009) TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11, 881-889
9. Putta, S., Lanting, L., Sun, G., Lawson, G., Kato, M. and Natarajan, R. (2012) Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol. 23, 458-469
10. Chung, A.C., Huang, X.R., Meng, X. and Lan, H.Y. (2010) miR-192 mediates TGF-β/Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 21, 1317-1325
11. Kalluri, R. and Weinberg, R.A. (2009) The basics of epithelial- mesenchymal transition. J. Clin. Invest. 119, 1420-1428
12. Kalluri, R. (2009) EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119, 1417-1419
13. Kim, T., Veronese, A., Pichiorri, F., Lee, T.J., Jeon, Y.J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.S. et al. (2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208, 875-883
14. Park, S.M., Gaur, A.B., Lengyel, E. and Peter, M.E. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (Pubitemid 351482843)
15. Gregory, P.A., Bert, A.G., Paterson, E.L., Barry, S.C., Tsykin, A., Farshid, G., Vadas, M.A., Khew-Goodall, Y. and Goodall, G.J. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (Pubitemid 351627379)
16. Brabletz, S. and Brabletz, T. (2010) The ZEB/miR-200 feedback loop: a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670-677
17. Carthew, R.W. and Sontheimer, E.J. (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655
18. Cullen, B.R. (2004) Transcription and processing of human microRNA precursors. Mol. Cell 16, 861-865
19. Filipowicz, W., Bhattacharyya, S.N. and Sonenberg, N. (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114
20. Hino, K., Tsuchiya, K., Fukao, T., Kiga, K., Okamoto, R., Kanai, T. and Watanabe, M. (2008) Inducible expression of microRNA-194 is regulated by HNF-1α during intestinal epithelial cell differentiation. RNA 14, 1433-1442 (Pubitemid 351872199)
21. Jenkins, R.H., Martin, J., Phillips, A.O., Bowen, T. and Fraser, D.J. (2012) Transforming growth factor β1 represses proximal tubular cell microRNA-192 expression via decreased hepatocyte nuclear factor DNA binding. Biochem. J. 443, 407-416
22. Xiong, M., Jiang, L., Zhou, Y., Qiu, W., Fang, L., Tan, R., Wen, P. and Yang, J. (2012) The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am. J. Physiol. Renal Physiol. 302, F369-F379
23. Meng, Z., Fu, X., Chen, X., Zeng, S., Tian, Y., Jove, R., Xu, R. and Huang, W. (2010) miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 52, 2148-2157
24. Mendell, J.T. (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133, 217-222
25. Olive, V., Bennett, M.J., Walker, J.C., Ma, C., Jiang, I., Cordon-Cardo, C., Li, Q.J., Lowe, S.W., Hannon, G.J. and He, L. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839-2849
26. Igarashi, P., Shao, X., McNally, B.T. and Hiesberger, T. (2005) Roles of HNF-1β in kidney development and congenital cystic diseases. Kidney Int. 68, 1944-1947 (Pubitemid 43117767)
27. Jiang, S., Tanaka, T., Iwanari, H., Hotta, H., Yamashita, H., Kumakura, J., Watanabe, Y., Uchiyama, Y., Aburatani, H., Hamakubo, T. et al. (2003) Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats. Nucl. Recept. 1, 5
28. Bingham, C. and Hattersley, A.T. (2004) Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1β. Nephrol., Dial., Transplant. 19, 2703-2708 (Pubitemid 39480961)
29. Pichiorri, F., Suh, S.S., Rocci, A., De Luca, L., Taccioli, C., Santhanam, R., Zhou, W., Benson, Jr, D.M., Hofmainster, C., Alder, H. et al. (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18, 367-381
30. Georges, S.A., Biery, M.C., Kim, S.Y., Schelter, J.M., Guo, J., Chang, A.N., Jackson, A.L., Carleton, M.O., Linsley, P.S., Cleary, M.A. and Chau, B.N. (2008) Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res. 68, 10105-10112
31. Boni, V., Bitarte, N., Cristobal, I., Zarate, R., Rodriguez, J., Maiello, E., Garcia-Foncillas, J. and Bandres, E. (2010) miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol. Cancer Ther. 9, 2265-2275
32. Braun, C.J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U.M., Schepeler, T., Orntoft, T.F., Andersen, C.L. and Dobbelstein, M. (2008) p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 68, 10094-10104
33. Feng, S., Cong, S., Zhang, X., Bao, X., Wang, W., Li, H., Wang, Z., Wang, G., Xu, J., Du, B. et al. (2011) MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res. 39, 6669-6678
34. Song, B., Wang, Y., Kudo, K., Gavin, E.J., Xi, Y. and Ju, J. (2008) miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin. Cancer Res. 14, 8080-8086
35. El-Dahr, S.S., Aboudehen, K. and Saifudeen, Z. (2008) Transcriptional control of terminal nephron differentiation. Am. J. Physiol. Renal Physiol. 294, F1273-F1278
36. Xu, H., He, J.H., Xiao, Z.D., Zhang, Q.Q., Chen, Y.Q., Zhou, H. and Qu, L.H. (2010) Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 52, 1431-1442
37. Zeng, X., Lin, Y., Yin, C., Zhang, X., Ning, B.F., Zhang, Q., Zhang, J.P., Qiu, L., Qin, X.R., Chen, Y.X. and Xie, W.F. (2011) Recombinant adenovirus carrying the hepatocyte nuclear factor-1α gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology 54, 2036-2047
38. Godwin, J.G., Ge, X., Stephan, K., Jurisch, A., Tullius, S.G. and Iacomini, J. (2010) Identification of a microRNA signature of renal ischemia reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 107, 14339-14344
39. Wang, G., Tam, L.S., Li, E.K., Kwan, B.C., Chow, K.M., Luk, C.C., Li, P.K. and Szeto, C.C. (2011) Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20, 493-500
40. Zarjou, A., Yang, S., Abraham, E., Agarwal, A. and Liu, G. (2011) Identification of a microRNA signature in renal fibrosis: role of miR-21. Am. J. Physiol. Renal Physiol. 301, F793-F801
41. Long, J., Wang, Y., Wang, W., Chang, B.H. and Danesh, F.R. (2011) MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 286, 11837-11848
42. Wang, G., Kwan, B.C., Lai, F.M., Choi, P.C., Chow, K.M., Li, P.K. and Szeto, C.C. (2010) Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab. Invest. 90, 98-103
43. Wang, G., Kwan, B.C., Lai, F.M., Choi, P.C., Chow, K.M., Li, P.K. and Szeto, C.C. (2010) Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am. J. Hypertens. 23, 78-84
44. Wang, X.X., Jiang, T., Shen, Y., Caldas, Y., Miyazaki-Anzai, S., Santamaria, H., Urbanek, C., Solis, N., Scherzer, P., Lewis, L. et al. (2010) Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 59, 2916-2927
45. Mizutani, A., Koinuma, D., Tsutsumi, S., Kamimura, N., Morikawa, M., Suzuki, H.I., Imamura, T., Miyazono, K. and Aburatani, H. (2011) Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4α in HepG2 cells. J. Biol. Chem. 286, 29848-29860
46. Minoo, P., Hu, L., Zhu, N., Borok, Z., Bellusci, S., Groffen, J., Kardassis, D. and Li, C. (2008) SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains. Nucleic Acids Res. 36, 179-188
47. Nagel, R., Clijsters, L. and Agami, R. (2009) The miRNA-192/194 cluster regulates the Period gene family and the circadian clock. FEBS J. 276, 5447-5455
48. Elvira-Matelot, E., Zhou, X.O., Farman, N., Beaurain, G., Henrion-Caude, A., Hadchouel, J. and Jeunemaitre, X. (2010) Regulation of WNK1 expression by miR-192 and aldosterone. J. Am. Soc. Nephrol. 21, 1724-1731